Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2289668911;68912;68913 chr2:178577740;178577739;178577738chr2:179442467;179442466;179442465
N2AB2125563988;63989;63990 chr2:178577740;178577739;178577738chr2:179442467;179442466;179442465
N2A2032861207;61208;61209 chr2:178577740;178577739;178577738chr2:179442467;179442466;179442465
N2B1383141716;41717;41718 chr2:178577740;178577739;178577738chr2:179442467;179442466;179442465
Novex-11395642091;42092;42093 chr2:178577740;178577739;178577738chr2:179442467;179442466;179442465
Novex-21402342292;42293;42294 chr2:178577740;178577739;178577738chr2:179442467;179442466;179442465
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Fn3-54
  • Domain position: 56
  • Structural Position: 77
  • Q(SASA): 0.1005
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/F None None 0.97 N 0.685 0.504 0.706391083165 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.7213 likely_pathogenic 0.7543 pathogenic -1.745 Destabilizing 0.822 D 0.579 neutral N 0.478805205 None None N
V/C 0.866 likely_pathogenic 0.8692 pathogenic -1.159 Destabilizing 0.998 D 0.667 neutral None None None None N
V/D 0.9605 likely_pathogenic 0.9687 pathogenic -2.133 Highly Destabilizing 0.89 D 0.733 prob.delet. N 0.513990211 None None N
V/E 0.9126 likely_pathogenic 0.9241 pathogenic -1.943 Destabilizing 0.956 D 0.665 neutral None None None None N
V/F 0.6713 likely_pathogenic 0.7102 pathogenic -1.076 Destabilizing 0.97 D 0.685 prob.neutral N 0.507775694 None None N
V/G 0.8597 likely_pathogenic 0.8782 pathogenic -2.256 Highly Destabilizing 0.89 D 0.723 prob.delet. N 0.473035215 None None N
V/H 0.9629 likely_pathogenic 0.9683 pathogenic -2.103 Highly Destabilizing 0.994 D 0.751 deleterious None None None None N
V/I 0.0809 likely_benign 0.0835 benign -0.344 Destabilizing 0.058 N 0.255 neutral N 0.45054723 None None N
V/K 0.9317 likely_pathogenic 0.9379 pathogenic -1.404 Destabilizing 0.956 D 0.669 neutral None None None None N
V/L 0.4516 ambiguous 0.4923 ambiguous -0.344 Destabilizing 0.489 N 0.527 neutral D 0.524639557 None None N
V/M 0.4433 ambiguous 0.4817 ambiguous -0.303 Destabilizing 0.978 D 0.651 neutral None None None None N
V/N 0.8764 likely_pathogenic 0.8951 pathogenic -1.617 Destabilizing 0.043 N 0.581 neutral None None None None N
V/P 0.964 likely_pathogenic 0.9653 pathogenic -0.781 Destabilizing 0.993 D 0.682 prob.neutral None None None None N
V/Q 0.8996 likely_pathogenic 0.9089 pathogenic -1.49 Destabilizing 0.956 D 0.698 prob.neutral None None None None N
V/R 0.9092 likely_pathogenic 0.9144 pathogenic -1.267 Destabilizing 0.956 D 0.754 deleterious None None None None N
V/S 0.8101 likely_pathogenic 0.833 pathogenic -2.222 Highly Destabilizing 0.915 D 0.683 prob.neutral None None None None N
V/T 0.7347 likely_pathogenic 0.7619 pathogenic -1.891 Destabilizing 0.86 D 0.624 neutral None None None None N
V/W 0.9883 likely_pathogenic 0.9896 pathogenic -1.607 Destabilizing 0.998 D 0.716 prob.delet. None None None None N
V/Y 0.9418 likely_pathogenic 0.9476 pathogenic -1.166 Destabilizing 0.993 D 0.67 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.